Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

509
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
509
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.6K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

376
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
376
Pneumonia IV: Management01:28

Pneumonia IV: Management

479
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
479
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.6K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Standard Precaution01:26

Standard Precaution

2.3K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heme orchestrates a tissue stress response to proteolytic damage.

bioRxiv : the preprint server for biology·2026
Same author

Host Response Diagnostics in Pneumonia.

Clinics in chest medicine·2026
Same author

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same author

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same author

Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a Trial.

Journal of the American Heart Association·2026
Same author

Risk heterogeneity within hypoinflammatory acute respiratory failure: continuous probabilities identify high-risk patients masked by binary classification.

Intensive care medicine·2026
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Oct 1, 2025

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K

New testing guidelines for community-acquired pneumonia.

Ashley Losier1, Charles S Dela Cruz

  • 1Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

Current Opinion in Infectious Diseases
|March 4, 2022
PubMed
Summary
This summary is machine-generated.

Current guidelines recommend influenza virus testing for community-acquired pneumonia (CAP) during spread. Other diagnostic tests are reserved for severe CAP or specific risk factors, with noninfluenza viral testing for hospitalized, immunocompromised patients.

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

50.6K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.3K

Related Experiment Videos

Last Updated: Oct 1, 2025

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.8K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

50.6K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.3K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) diagnosis and treatment rely on accurate diagnostic testing.
  • Guidelines from the American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) and a 2021 ATS guideline inform diagnostic strategies.
  • Diagnostic testing is crucial for confirming CAP and guiding appropriate therapy.

Purpose of the Study:

  • To review current diagnostic testing recommendations for CAP from the ATS/IDSA guideline.
  • To examine the 2021 ATS guideline on molecular testing for noninfluenza respiratory viruses in adults with suspected CAP.
  • To synthesize evidence-based recommendations for diagnostic testing in CAP.

Main Methods:

  • Review of the current ATS/IDSA CAP diagnostic testing guideline.
  • Review of the 2021 ATS clinical practice guideline for noninfluenza respiratory viruses.
  • Analysis of recommendations based on CAP severity and specific pathogen risk factors.

Main Results:

  • Gram stain, lower respiratory and blood cultures, and urinary antigen tests for Streptococcus and Legionella are not routinely recommended for CAP unless severe or risk factors for MRSA/Pseudomonas are present.
  • Influenza virus testing is strongly recommended during periods of community viral spread.
  • Molecular testing for noninfluenza viral pathogens is recommended for hospitalized adults with severe CAP and/or immunocompromising conditions.

Conclusions:

  • Diagnostic testing remains vital for CAP management.
  • Influenza testing is a priority during community outbreaks.
  • Broader use of other diagnostic tests, including noninfluenza viral tests, is reserved for specific clinical scenarios such as severe disease or immunocompromise.